As a global leader in #protontherapy, Penn Medicine is leading a nationwide, randomized clinical trial to compare proton and standard radiation for breast cancer treatment. Justin Bekelman, MD, spoke about the importance of the study in @PhillyInquirer. t.co/k69hzo0g1f